1. What is the current market size of the PET-CT scanning market?
The global PET-CT scanning market was valued at approximately USD 2.1 billion in 2024 and is projected to reach USD 3.8 billion by 2034, growing at a CAGR of 6.1%.
+1 2315155523
Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
Research Analyst


The global PET-CT scanning market represents a critical segment of advanced molecular imaging, combining positron emission tomography (PET) functional data with computed tomography (CT) anatomical detail. Our proprietary primary research estimates the market at USD 2.1 billion in 2024, with a projected expansion to USD 3.8 billion by 2034, reflecting a robust CAGR of 6.1% . This growth is underpinned by the indispensable role of hybrid imaging in oncology, cardiology, and neurology, alongside rapid technological upgrades from analog to digital detectors and the integration of artificial intelligence.
North America retains the dominant revenue share at 34.1% , driven by high procedure volumes, favorable reimbursement, and a concentrated presence of leading OEMs. However, Asia-Pacific is emerging as the fastest-growing region, fueled by healthcare infrastructure investments and rising cancer incidence.
The PET-CT scanning value chain is characterized by high complexity and multiple specialized stakeholders.
The PET-CT scanner market is a high-value, low-volume trade segment. According to our trade data analysis, the U.S., Germany, and Japan are the largest exporters of PET-CT systems, while China and emerging economies are major importers. Supply chain risks include:
Companies are mitigating these risks through regional manufacturing and strategic inventory management.
| Region | Market Share (2024) | Growth Outlook |
|---|---|---|
| North America | 34.1% | Mature, driven by replacement demand and digital upgrades |
| Europe | 24.0% | Stable growth, with emphasis on value-based care |
| Asia-Pacific | 28.0% | Fastest-growing, led by China and India |
| South America | 6.0% | Emerging, with Brazil and Mexico as key markets |
| Middle East & Africa | 8.0% | Improving infrastructure and medical tourism |
The PET-CT market is moderately consolidated, with the top five OEMs holding a majority share. Key strategies include:
Significant opportunities exist in:
Companies investing in these areas are poised to capture disproportionate growth in the coming decade.
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 6.1% from 2020-2034 |
| Segmentation |
|
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
| Stakeholder Role | Interview Share (%) |
|---|---|
| C-Level Executives | 30% |
| Radiology Department Heads | 25% |
| Nuclear Medicine Specialists | 25% |
| Procurement Managers | 20% |
| Company Type | Representation (%) |
|---|---|
| PET-CT Scanner OEMs | 40% |
| Radiopharmaceutical Suppliers | 25% |
| Diagnostic Imaging Centers | 20% |
| Hospital Procurement Departments | 15% |
The global PET-CT scanning market was valued at approximately USD 2.1 billion in 2024 and is projected to reach USD 3.8 billion by 2034, growing at a CAGR of 6.1%.
PET-CT is the dominant modality, holding over 81% revenue share in 2023, due to its broad clinical utility and cost-effectiveness compared to PET-MRI.
Key drivers include rising cancer incidence, technological advancements such as digital detectors and AI, and the expanding portfolio of radiopharmaceuticals.
Asia-Pacific is projected to be the fastest-growing region, driven by increasing healthcare investments and rising disease prevalence, while North America remains the largest market.